24,988 Shares in Solventum Co. (NYSE:SOLV) Purchased by Ontario Teachers Pension Plan Board

Ontario Teachers Pension Plan Board purchased a new position in Solventum Co. (NYSE:SOLV) during the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 24,988 shares of the company’s stock, valued at approximately $1,742,000.

A number of other institutional investors also recently bought and sold shares of SOLV. Price T Rowe Associates Inc. MD acquired a new position in shares of Solventum during the 1st quarter worth approximately $5,889,000. Mitsubishi UFJ Trust & Banking Corp purchased a new position in Solventum during the first quarter valued at $5,747,000. CWM LLC acquired a new stake in shares of Solventum in the second quarter valued at about $473,000. Great Valley Advisor Group Inc. purchased a new stake in shares of Solventum during the second quarter worth about $493,000. Finally, First Horizon Advisors Inc. purchased a new position in Solventum in the 2nd quarter valued at about $58,000.

Solventum Price Performance

Shares of SOLV opened at $68.39 on Thursday. The firm’s fifty day simple moving average is $70.49 and its 200-day simple moving average is $62.26. The company has a debt-to-equity ratio of 2.45, a quick ratio of 0.83 and a current ratio of 1.15. Solventum Co. has a twelve month low of $47.16 and a twelve month high of $96.05.

Analyst Ratings Changes

Several equities analysts have recently weighed in on the company. Piper Sandler raised their target price on Solventum from $71.00 to $75.00 and gave the company a “neutral” rating in a research report on Friday, November 8th. Stifel Nicolaus assumed coverage on shares of Solventum in a research note on Tuesday, October 8th. They issued a “buy” rating and a $82.00 price target on the stock. BTIG Research started coverage on shares of Solventum in a research note on Thursday, September 5th. They set a “neutral” rating for the company. Wells Fargo & Company lowered their target price on Solventum from $69.00 to $64.00 and set an “equal weight” rating on the stock in a report on Friday, August 9th. Finally, The Goldman Sachs Group increased their price target on Solventum from $48.00 to $54.00 and gave the company a “sell” rating in a report on Monday, August 12th. One analyst has rated the stock with a sell rating, eight have given a hold rating and one has assigned a buy rating to the stock. According to data from MarketBeat.com, Solventum has a consensus rating of “Hold” and a consensus target price of $68.00.

Solventum Company Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.